Solubilizer

Bioavailability, one of the prime pharmacokinetic properties of a drug, is defined as the fraction of an administered dose of...

To improve the dissolution and oral bioavailability of valsartan (VST), we previously formulated a supersaturable self-microemulsifying drug delivery system (SuSMED)...

Electrospinning can be an interesting downstreaming continuous manufacturing technology. Pharmaexcipients.com lately published a series of articles from MDPI adressing this topic....

The present study explores the effect of melt binding of Soluplus® on in vitro release profiles of two hydrophilic drugs,...

An ideal cancer therapy targets the tumor cells selectively without damaging healthy tissues. Even though the tumor-specific markers are limited,...

Self-dispersing lipid-based formulations, particularly self-microemulsifying drug delivery systems (SMEDDS) have gained an increased interest in recent times as a means...

Lipid-based formulations, including self-emulsifying drug delivery systems (SEDDS), are an interesting formulation technology that enables the clinical use of compounds...

Implication of Quantitative Selection of Each Excipient in Product Development Excipients’ role in designing different dosage forms does not require...

In last few years, therapeutic peptides/proteins are rapidly growing in drug market considering their higher efficiency and lower toxicity than...

Carbopol® 971 and poly(2-ethyl-2-oxazoline) form hydrogen-bonded interpolymer complexes in aqueous solutions and their complexation is strongly dependent on solution pH....